Toronto, Canada, October 28, 2009 – MedX Health Corp., (TSXV.MDX) a global leader in developing drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced that the company will be a first-time exhibitor at MEDICA 2009 41st World Forum for Medicine, International Trade Fair with Congress. Earlier in 2009 MedX Health had announced the establishment of its first European Distribution Center in The Netherlands, following receipt of the CE Mark approval to market and sell the family of MedX laser and light products in all European Union (EU) and three European Free Trade Association Member (EFTA) states, MedX, better serving its EU and EFTA customers. In addition, MedX announced the appointment of Frank Raymakers as Director of European Sales, to oversee operations, and joining the International commercial team of Larry Petersen, Director of International Business Development, and Pete Holmes, Vice President, Worldwide Sales.
“We made a strong commitment to globalize our low level cold laser and light products. We have recently established our EU Distribution Center in The Netherlands, and have obtained the CE Mark for all of our laser and light products. MedX is also rapidly expanding a worldwide network of new distributors,” states Steve Guillen, President and CEO of MedX Health. “The MEDICA meeting brings together our current and potential partners to share their ideas and products, and our participation will accelerate our success in the global market.”
Visitors can see a demonstration of the Laser technology live by visiting Hall 5, Booth N 40
MedX Health is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technology for use in numerous medical settings that provide patients with non-invasive, drug-free solutions for improving clinical outcomes. MedX’s innovative Laser/Light Therapy devices enhance the patient’s quality of life and improve the standard of care for tissue repair and pain relief.
MedX is establishing new strategic partnerships and our OEM manufacturing, while continuing to develop and acquire new dental, rehabilitation and wound care products. In particular, MedX plans to accelerate the development of a new product aimed at the rapidly-growing wound care market. Recently, MedX announced a new patent allowance for bone growth that will join several key existing patents, including “Photobandage” a new technology that allows a wound to be bathed in light and is designed to enhance the healing process. The Company intends to license its proprietary wound care technologies to one or more major wound care companies for further development, marketing and commercialization.
President and Chief Executive Officer
MedX Health Corp.
Phone: 1-(905)826-0766 Ext. 226
Director European Sales
Director International Business
1-303-489-2500 Email: Petersen@medxhealth.com
Skype Name: medx.health